Sulphonylurea efficacy and end-organ outcomes in the management of HNF4A-MODY. Crowley MT, Ng N, Goulden E, Sanchez-Lechuga B, et al. Diabet Med 2025;42:e70139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crowley MT, Ng N, Goulden E, Sanchez-Lechuga B, et al. Sulphonylurea efficacy and end-organ outcomes in the management of HNF4A-MODY. Diabet Med 2025;42:e70139.
PMID: 40954556